PMID- 10051769 OWN - NLM STAT- MEDLINE DCOM- 19990421 LR - 20190815 IS - 0953-816X (Print) IS - 0953-816X (Linking) VI - 11 IP - 2 DP - 1999 Feb TI - Neurotrophic factors modulate hair cells and their potassium currents in chick otocyst explants. PG - 682-90 AB - Neurotrophins, retinoids and their receptors are present in the sensory epithelia of the inner ear during development. We show that these factors modulate the proliferation of hair cells and their K+-currents when the embryonic day 3 (ED 3) presumptive inner ear (i.e. otocyst) is maintained in organ culture. All trans-retinoic acid (RA) increases hair cell differentiation and enhances the acquisition of outward currents, including a delayed rectifier and a fast activating, transient type, voltage-gated potassium current. In contrast, brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) decrease ionic current activity, and the addition of RA with the neurotrophins enhances this inhibitory response in an age-dependent manner. We measured the total number of cells per explant over time to determine precisely when and how these factors inhibit explant growth. We found that high concentrations of BDNF and NT-3 administered together, and low concentrations of both neurotrophins combined and administered with RA suppress otocyst cell numbers after 24 h in vitro. This suppressive response is induced by RA and NT-3, not by RA and BDNF. The suppressive or inhibitory influence of NT-3 and RA is the result of NT-3 binding to the low affinity receptor, p75NTR, not the result of RA increasing mRNA levels for the high affinity receptor, trkC. However, trk may act with p75NTR, as disruption of trk signalling alleviates the inhibitory response induced by NT-3 and RA. Our data suggest that various combinations and/or concentration gradients of these factors can differentially regulate inner ear development and hair cell excitability. FAU - Sokolowski, B H AU - Sokolowski BH AD - University of South Florida, Department of Otolaryngology-Head and Neck Surgery, Tampa 33612, USA. FAU - Csus, J AU - Csus J FAU - Hafez, O I AU - Hafez OI FAU - Haggerty, H S AU - Haggerty HS LA - eng GR - DC01923/DC/NIDCD NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - France TA - Eur J Neurosci JT - The European journal of neuroscience JID - 8918110 RN - 0 (Antineoplastic Agents) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Nerve Growth Factors) RN - 0 (Neurotrophin 3) RN - 0 (RNA, Messenger) RN - 0 (Receptor, Ciliary Neurotrophic Factor) RN - 0 (Receptor, Nerve Growth Factor) RN - 0 (Receptors, Nerve Growth Factor) RN - 5688UTC01R (Tretinoin) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 2.7.10.1 (Receptor, trkC) RN - RWP5GA015D (Potassium) SB - IM EIN - Eur J Neurosci 1999 May;11(5):1847 MH - Aging/physiology MH - Animals MH - Antineoplastic Agents/pharmacology MH - Brain-Derived Neurotrophic Factor/*pharmacology MH - Cell Division/drug effects MH - Chick Embryo MH - Gene Expression/physiology MH - Hair Cells, Auditory/chemistry/cytology/*physiology MH - Membrane Potentials/drug effects/physiology MH - Nerve Growth Factors/*pharmacology MH - Neurotrophin 3 MH - Organ Culture Techniques MH - Patch-Clamp Techniques MH - Potassium/*metabolism MH - RNA, Messenger/analysis MH - Receptor Protein-Tyrosine Kinases/genetics/metabolism MH - Receptor, Ciliary Neurotrophic Factor MH - Receptor, Nerve Growth Factor MH - Receptor, trkC MH - Receptors, Nerve Growth Factor/genetics/metabolism/physiology MH - Tretinoin/metabolism/pharmacology EDAT- 1999/03/03 00:00 MHDA- 1999/03/03 00:01 CRDT- 1999/03/03 00:00 PHST- 1999/03/03 00:00 [pubmed] PHST- 1999/03/03 00:01 [medline] PHST- 1999/03/03 00:00 [entrez] AID - 10.1046/j.1460-9568.1999.00469.x [doi] PST - ppublish SO - Eur J Neurosci. 1999 Feb;11(2):682-90. doi: 10.1046/j.1460-9568.1999.00469.x.